Establish minimum dose for a CCPP bacterin vaccine
Data and Resources
-
Inactivation of Mccp using hydrogen peroxide - ...
Establish minimum dose for a CCPP bacterin vaccine, an activity within TAHSSL
Available formats
-
Inactivation of Mccp using H2O2 - Report
Establish minimum dose for a CCPP bacterin vaccine, an activity within TAHSSL
Available formats
Dataset metadata
Item | Value |
---|---|
Created | Monday 1st of March, 2021 |
Last updated | Wednesday 3rd of March, 2021 |
Dataset type | Non-spatial |
Abstract | Overall aim of the project is to improve the inactivated CCPP vaccine, by changing to faster growing and more recently isolated strain, by titrating the antigen and by replacing saponin with other inactivation method and another adjuvant |
How this dataset could be used by others | Information on possible inactivation method for vaccine development |
Principal investigator | Elise Scheick |
Principal investigator email | e.schieck@cgiar.org |
Contact person | Elise Schieck |
Contact email | e.schieck@cgiar.org |
Custodian | Elise Schieck |
Custodian email | e.schieck@cgiar.org |
Groups | |
AGROVOC Tags | |
Regions | |
Countries | |
Data collected from | 01/07/2020 |
Data collected to | 31/12/2020 |
License | Creative Commons Attribution |
Release of confidential data? | No |
Consent obtained? | No |
Intellectual Property Ownership | ILRI |
Citation | Elise Scheick (NaN). Establish minimum dose for a CCPP bacterin vaccine. ILRI. Available at https://data.ilri.org/dataset/establish-minimum-dose-for-a-ccpp-bacterin-vaccine, retrieved on (add date here) |
Acknowledgements | Stephen Mwalimu, Winnie Chebore and Rose Ojuok |
Project metadata
Item | Value |
---|---|
Project title | Establish minimum dose for a CCPP bacterin vaccine |
Project abstract | Overall aim of the project is to improve the inactivated CCPP vaccine, by changing to faster growing and more recently isolated strain, by titrating the antigen and by replacing saponin with other inactivation method and another adjuvant |
Grant code | BMG024 |
Donor | BMGF |
Partners | GALVmed, ClinGlobal |
Start date | 01/01/2019 |
End date | 31/08/2021 |
Principal investigator | Elise Schieck |
Regions | |
Countries |